Published in Cancer Weekly, October 16th, 1995
Gliadel is a biodegradable polymer implant which is being developed by Guilford for the treatment of malignant glioma, the most common and rapidly fatal type of brain cancer. Gliadel polymer implants are small white wafers which are left in the surgical cavities created when a brain tumor is removed. As the wafer slowly erodes in the brain, it releases the cancer chemotherapeutic drug carmustine (BCNU) directly to the tumor site in high concentrations over an extended...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.